Research programme: spinal stem cell therapeutics - DiscGenicsAlternative Names: Allogeneic therapeutic progenitor cells - DiscGenics; Discogenic cells; Discospheres™; IDCT - DiscGenics; Injectable discogenic cell therapy - DiscGenics
Latest Information Update: 11 Nov 2016
At a glance
- Originator DiscGenics
- Class Stem cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Intervertebral disc degeneration